Nadege Carrie
Overview
Explore the profile of Nadege Carrie including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
12
Citations
372
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Eckmann J, Fauti T, Biehl M, Zabaleta A, Blanco L, Lelios I, et al.
Blood
. 2024 Oct;
145(2):202-219.
PMID: 39476124
Despite several approved therapies, multiple myeloma (MM) remains an incurable disease with high unmet medical need. "Off-the-shelf" T-cell bispecific antibodies (TCBs) targeting B-cell maturation antigen (BCMA) and G protein-coupled receptor...
2.
Blanquart E, Ekren R, Rigaud B, Joubert M, Baylot V, Daunes H, et al.
Blood
. 2024 Jun;
144(12):1271-1283.
PMID: 38875515
The promising results obtained with immunotherapeutic approaches for multiple myeloma (MM) call for a better stratification of patients based on immune components. The most pressing being cytotoxic lymphocytes such as...
3.
Pichler A, Carrie N, Cuisinier M, Ghazali S, Voisin A, Axisa P, et al.
Immunity
. 2023 Jul;
56(7):1631-1648.e10.
PMID: 37392737
CD137 (4-1BB)-activating receptor represents a promising cancer immunotherapeutic target. Yet, the cellular program driven by CD137 and its role in cancer immune surveillance remain unresolved. Using T cell-specific deletion and...
4.
Kassem S, Diallo B, El-Murr N, Carrie N, Tang A, Fournier A, et al.
Blood
. 2022 Feb;
139(8):1160-1176.
PMID: 35201323
Anti-CD38 monoclonal antibodies (mAbs) represent a breakthrough in the treatment of multiple myeloma (MM), yet some patients fail to respond or progress quickly with this therapy, highlighting the need for...
5.
Weulersse M, Asrir A, Pichler A, Lemaitre L, Braun M, Carrie N, et al.
Immunity
. 2020 Oct;
53(4):824-839.e10.
PMID: 33053331
CD8 T cells within the tumor microenvironment (TME) are exposed to various signals that ultimately determine functional outcomes. Here, we examined the role of the co-activating receptor CD226 (DNAM-1) in...
6.
Guillerey C, Harjunpaa H, Carrie N, Kassem S, Teo T, Miles K, et al.
Blood
. 2018 Jul;
132(16):1689-1694.
PMID: 29986909
Immune-based therapies hold promise for the treatment of multiple myeloma (MM), but so far, immune checkpoint blockade targeting programmed cell death protein 1 has not proven effective as single agent...
7.
Stienne C, Michieletto M, Benamar M, Carrie N, Bernard I, Nguyen X, et al.
Immunity
. 2016 Oct;
45(4):774-787.
PMID: 27742544
The transcription factor Foxo3 plays a crucial role in myeloid cell function but its role in lymphoid cells remains poorly defined. Here, we have shown that Foxo3 expression was increased...
8.
Ramadan A, Lucca L, Carrie N, Desbois S, Axisa P, Hayder M, et al.
Brain
. 2016 Mar;
139(Pt 5):1433-46.
PMID: 27000832
Polyspecific T cells recognizing multiple distinct self-antigens have been identified in multiple sclerosis and other organ-specific autoimmune diseases, but their pathophysiological relevance remains undetermined. Using a mouse model of multiple...
9.
Lucca L, Desbois S, Ramadan A, Ben-Nun A, Eisenstein M, Carrie N, et al.
J Immunol
. 2014 Aug;
193(7):3267-77.
PMID: 25135834
The recognition of multiple ligands by a single TCR is an intrinsic feature of T cell biology, with important consequences for physiological and pathological processes. Polyspecific T cells targeting distinct...
10.
Saxena A, Desbois S, Carrie N, Lawand M, Mars L, Liblau R
J Immunol
. 2012 Aug;
189(6):3140-9.
PMID: 22904307
An increase in IL-17-producing CD8+ T (Tc17) cells has been reported in the peripheral blood of children with recent onset type 1 diabetes (T1D), but their contribution to disease pathogenesis...